These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29623391)

  • 1. Association between memory B-cells and clinical and immunological features of primary Sjögren's syndrome and Sicca patients.
    Barcelos F; Martins C; Papoila A; Geraldes C; Cardigos J; Nunes G; Lopes T; Alves N; Vaz-Patto J; Branco J; Borrego LM
    Rheumatol Int; 2018 Jun; 38(6):1063-1073. PubMed ID: 29623391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of lymphocyte phenotype profile to differentiate primary Sjögren's syndrome from sicca syndrome.
    Loureiro-Amigo J; Palacio-García C; Martínez-Gallo M; Martínez-Valle F; Ramentol-Sintas M; Soláns-Laqué R
    Rheumatology (Oxford); 2021 Dec; 60(12):5647-5658. PubMed ID: 33620072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
    Loureiro-Amigo J; Franco-Jarava C; Perurena-Prieto J; Palacio C; Martínez-Valle F; Soláns-Laqué R
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):131-139. PubMed ID: 34919042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal sub-basal nerve plexus assessment and its association with phenotypic features and lymphocyte subsets in Sjögren's Syndrome.
    Barcelos F; Hipólito-Fernandes D; Martins C; Ângelo-Dias M; Cardigos J; Monteiro R; Alves N; Vaz-Patto J; da Cunha-Branco J; Borrego LM
    Acta Ophthalmol; 2021 Dec; 99(8):e1315-e1325. PubMed ID: 33683020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
    Szabó K; Papp G; Szántó A; Tarr T; Zeher M
    Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren's Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution.
    Szabó K; Jámbor I; Szántó A; Horváth IF; Tarr T; Nakken B; Szodoray P; Papp G
    Front Immunol; 2021; 12():639975. PubMed ID: 33815392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndrome.
    Genç D; Günaydın B; Sezgin S; Aladağ A; Tarhan EF
    Immunotherapy; 2022 Mar; 14(4):225-247. PubMed ID: 35012368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.
    Bohnhorst JØ; Bjørgan MB; Thoen JE; Natvig JB; Thompson KM
    J Immunol; 2001 Oct; 167(7):3610-8. PubMed ID: 11564773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte subpopulations in Sjögren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.
    Barcelos F; Martins C; Madeira N; Ângelo-Dias M; Cardigos J; Alves N; Vaz-Patto J; Cunha-Branco J; Borrego LM
    Clin Rheumatol; 2021 Jul; 40(7):2791-2804. PubMed ID: 33443605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records.
    Sandhya P; Janardana R; Sudarsanam T; Mahasampath G; Prakash JAJ; Danda D
    Int J Rheum Dis; 2019 Sep; 22(9):1768-1774. PubMed ID: 31328441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.
    Roberts ME; Kaminski D; Jenks SA; Maguire C; Ching K; Burbelo PD; Iadarola MJ; Rosenberg A; Coca A; Anolik J; Sanz I
    Arthritis Rheumatol; 2014 Sep; 66(9):2558-69. PubMed ID: 24909310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
    Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
    J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.
    Li L; He J; Zhu L; Yang Y; Jin Y; Jia R; Liu X; Liu Y; Sun X; Li Z
    J Immunol Res; 2015; 2015():307453. PubMed ID: 26436101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.